191 related articles for article (PubMed ID: 10374779)
21. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
Klebe S; Swalling A; Jonavicius L; Henderson DW
J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
[TBL] [Abstract][Full Text] [Related]
22. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
23. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Ordóñez NG
Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522
[TBL] [Abstract][Full Text] [Related]
24. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines.
Fujita J; Ohtsuki Y; Bandoh S; Ueda Y; Kubo A; Tojo Y; Yamaji Y; Ishida T
Lung Cancer; 2003 Jan; 39(1):31-6. PubMed ID: 12499091
[TBL] [Abstract][Full Text] [Related]
25. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
26. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
27. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
Ordóñez NG
Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
[TBL] [Abstract][Full Text] [Related]
29. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.
Han AC; Peralta-Soler A; Knudsen KA; Wheelock MJ; Johnson KR; Salazar H
Hum Pathol; 1997 Jun; 28(6):641-5. PubMed ID: 9190996
[TBL] [Abstract][Full Text] [Related]
31. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.
Kalhor N; Zander DS; Liu J
Mod Pathol; 2006 Aug; 19(8):1117-23. PubMed ID: 16680154
[TBL] [Abstract][Full Text] [Related]
32. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Chang YL; Lee YC; Liao WY; Wu CT
Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
[TBL] [Abstract][Full Text] [Related]
33. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
[TBL] [Abstract][Full Text] [Related]
34. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
35. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
[TBL] [Abstract][Full Text] [Related]
37. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Turner BM; Cagle PT; Sainz IM; Fukuoka J; Shen SS; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
[TBL] [Abstract][Full Text] [Related]
38. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.
Ordóñez NG
Hum Pathol; 1998 Feb; 29(2):166-9. PubMed ID: 9490276
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.
Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C
Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]